U.S. Packaging Stock News

T. Rowe Price Group stock has delivered a decline of about 35.0% over the past 5 years, yet current valuation checks and the intrinsic value estimate from the Excess Returns model both indicate the shares may be trading at a discount to what the business could be worth. The roughly 35.0% share price decline over 5 years means long term holders have seen meaningful capital losses despite more recent gains. Investor focus on earnings prospects for smaller companies, highlighted by interest in...

UMH Properties stock sits at the center of a valuation split, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to a sizeable potential discount, while traditional market multiples suggest the shares already trade at a premium. The stock has also delivered mixed long term returns, which adds another layer to the debate about what investors are really paying for. Over the past 5 years the share price is down about 20%, which means long term holders have not...

LeMaitre Vascular (LMAT) has drawn investor attention after recent share price moves, with the stock closing at $101.32 on 29 July 2026. The company operates in the medical devices segment focused on vascular surgery. See our latest analysis for LeMaitre Vascular. Recent trading reflects that momentum in LeMaitre Vascular has cooled slightly in the very short term, with a 1 day share price return that declined 0.85%, following a strong year to date share price return of 26.38% and a 5 year...

Modine Manufacturing Company recently reported past first-quarter fiscal 2027 results, with sales rising to US$874.1 million and net income to US$73.9 million, alongside diluted earnings per share from continuing operations of US$1.37. At the same time, management issued new guidance calling for fiscal 2027 net sales to increase by 20% to 35%, underlining confidence in demand for its data center and advanced thermal solutions businesses. Now we’ll examine how Modine’s stronger quarterly...

Life Time Group Holdings walked into this earnings print with its stock already on a strong run, up roughly 69% over the past three months and another 2% on the day around the release. For a fitness and wellness operator often framed as a long term growth story, the headline this quarter is straightforward. Revenue reached about US$866m and net income came in just over US$100m, while adjusted EBITDA margin moved into the high 20s. The market reaction so far suggests investors are treating...

Coinbase Global is waking up to a harsh verdict. The stock dropped about 11% to roughly US$146 after investors reacted to fresh quarterly numbers that showed another loss and softer revenue. The short term message is blunt. Crypto volumes and fee income are not doing enough right now to offset the cost base. The long term question is very different. Coinbase is still being valued at more than 6x sales while trailing twelve month earnings sit in the red. The key takeaway from this earnings...

In late July 2026, Novo Nordisk reported that its late-stage ZEUS trial for the anti-inflammatory drug ziltivekimab did not meet its primary goal, prompting investors to reassess the broader inflammation-focused drug landscape. Because Monte Rosa Therapeutics works on inflammation-related biology, this setback for a large pharmaceutical peer heightened scrutiny of its own scientific approach and pipeline risk profile. We will now examine how this high-profile anti-inflammatory trial...

Eversource Energy stock has delivered a 22.2% return over the past three years, yet its current valuation sends mixed signals, with the Dividend Discount Model (DDM) implying the shares trade at a premium while earnings based multiples point to better value. The 22.2% three year return suggests Eversource Energy has already rewarded patient shareholders, which raises the bar for any new upside from here. The refocus on regulated electric and natural gas delivery after the Aquarion Water sale...

Curtiss-Wright (CW) heads into its June 2026 quarter earnings with expectations for growth in earnings per share, after analysts raised their consensus forecasts over the past month. See our latest analysis for Curtiss-Wright. The recent pullback, with a 7 day share price return of 3.49% and a 30 day share price return of 4.46%, contrasts with Curtiss-Wright’s stronger year to date share price return of 26.49% and a 5 year total shareholder return above 5x. This suggests longer term momentum...

The GEO Group, Inc. recently announced a five-year support services contract with U.S. Immigration and Customs Enforcement for exclusive use of its 1,320-bed Rivers Facility in Winton, North Carolina, which is expected to generate about US$80,000,000 in annual revenue in its first full year. The agreement deepens GEO’s role in federal immigration processing by bundling security, maintenance, food service, recreation, medical care, and access to legal counsel into a single, long-term...

AI linked cyber attacks from OpenAI and Anthropic have pushed cybersecurity risk from background concern to front page story. Investors are now weighing where the real winners and weak spots might sit as regulators talk tougher rules and legal liability for AI driven breaches. This screener focuses on larger cybersecurity companies whose tools help protect networks, endpoints and cloud systems. The article will walk through 3 stocks that appear positively exposed to this surge in attention on...

Capital One Financial has delivered a 92.4% share price gain over the past three years, yet its current checks still point to a stock that screens as undervalued rather than fully priced in. Both the Excess Returns intrinsic value estimate and market multiples lean in the same direction, which puts more focus on whether that apparent discount is justified by the risks now in view. Over the past three years the stock is up 92.4%. This means anyone looking at Capital One Financial today is...

General Electric (GE) is back in focus after Philippine Airlines agreed to use its GEnx 1B engines on a future Boeing 787 10 fleet, drawing attention to the company’s commercial aerospace franchise. See our latest analysis for General Electric. That Philippine Airlines deal arrives as General Electric shares hold at US$360.07, with a 90 day share price return of 25.67% and a 1 year total shareholder return of 34.34%. This points to momentum that has built over a multi year period, despite a...

In July 2026, National Bank Holdings Corporation reported second-quarter and first-half 2026 results, with net interest income rising to US$109.29 million for the quarter and US$218.09 million for the half-year, while net income and earnings per share from continuing operations declined compared with the prior year periods. Alongside these mixed earnings, the company also completed a tranche of its January 2026 share repurchase program, buying back 664,579 shares for US$27.21 million in...

Regeneron Pharmaceuticals stock jumped about 3% to around US$763 after its latest report, a clear sign traders liked what they saw in the headline numbers. The bigger story sits in the profit engine behind that move. Quarterly basic earnings per share came in at US$12.62 on revenue of US$4.29b, while trailing net margin stands at 27.9%, compared with 31.4% a year earlier. In the short term, the market is cheering the earnings print. Over a longer horizon, investors now have to weigh that...

In July 2026, Red Cat Holdings, Inc. disclosed that its Board had decided to terminate Chief Revenue Officer Geoffrey Hitchcock for cause, prompting Hitchcock to file a civil complaint alleging retaliatory termination, breach of contract, and related claims, while the company denies wrongdoing and plans a vigorous legal defense without severance or accelerated equity for him. On the upside for operations, Red Cat’s Teal Drones subsidiary secured a US$2.49 million firm-fixed-price contract...

STERIS plc has increased its quarterly interim dividend to US$0.69 per share, up US$0.06, marking its 21st consecutive year of dividend growth, with the payment made on 25 September 2026 to shareholders of record on 4 September 2026. This extended streak of rising dividends underlines management’s consistent commitment to shareholder returns and may matter for investors focused on income reliability. We’ll now examine how this higher quarterly dividend and long track record of dividend...

Cigna Group stock was essentially flat over the past month going into the earnings release, then slipped almost 3% to about US$279 as investors digested the latest numbers. The market is reacting to headlines, but the earnings story centers on profit power. Adjusted EPS guidance has been lifted to at least US$30.45 for 2026, while quarterly adjusted EPS came in at US$7.78 on US$71.7 billion of revenue. That combination of a sliding share price and firmer earnings guidance sets up a clear...

ACM Research (ACMR) has drawn investor attention after recent share price swings, including a decline of about 33% over the past month while still showing a very large total return over the past 3 years. See our latest analysis for ACM Research. Recent trading has been choppy for ACM Research, with the share price down about 33% over the past month and 7% over the past week. However, the year to date share price return of about 75% and a very large three year total shareholder return suggest...

Belden stock jumped about 6% today to roughly US$124 after investors reacted to a Q2 earnings beat that leaned heavily on profits rather than just top line growth. Adjusted earnings per share reached US$2.34 on US$750.2m of revenue, which put fresh attention on how much profit Belden can squeeze from each networking and industrial automation dollar. The short term move is eye catching. The bigger story is the long term profit engine that investors now have to weigh against a more leveraged...

Iovance Biotherapeutics stock has delivered a strong rebound over the past year, yet longer term holders are still facing steep losses, so the current valuation attracts close attention. The share price now sits against a backdrop where the broader checks lean cheap. This raises the question of whether the market is still underpricing the company or simply adjusting after a difficult few years. Over 5 years, Iovance Biotherapeutics is down 82.7%, which means many long term investors are...

In July 2026, Gentherm Incorporated reported second-quarter 2026 net income of US$4.42 million and diluted EPS of US$0.14 from continuing operations, alongside the completion of a prior 1,021,070‑share buyback for US$39.9 million and the authorization of a new share repurchase program of up to US$400 million through July 2029. This combination of stronger profitability and a larger, freshly approved repurchase authorization signals management’s confidence in the business while potentially...

Shinhan Bank previously announced a partnership with StoneX Group Inc.’s Payments Division to integrate StoneX Payments’ platform, extending comprehensive cross-border payment and foreign exchange services across more than 140 currencies and 180 countries through a network of over 385 banks. This collaboration deepens StoneX’s presence in South Korea and the wider Asia-Pacific region by supporting high-volume, complex flows into thinly traded currency corridors in Latin America, the Middle...

NBT Bancorp Inc. recently reported second-quarter 2026 results, with net interest income of US$136.96 million and net income of US$53.03 million, alongside higher loan net charge-offs of US$4.24 million compared with the prior year. The company also approved a third-quarter 2026 dividend of US$0.40 per share, its fourteenth consecutive annual increase, and completed a US$44.11 million share repurchase program that reduced its share count by 2.39%, signaling ongoing emphasis on shareholder...